Successful use of agomelatine and venlafaxine combination in major depression

General Hospital Psychiatry

Volumn 36, Issue 1, 2014, Pages

  Dahale, Ajit Bhalchandra ^a   Narayanaswamy, Janardhanan C ^a   Venkatasubramanian, Ganesan ^a   Bagewadi, Virupakshappa Irappa ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AGOMELATINE; FLUOXETINE; VENLAFAXINE;

ADD ON THERAPY; ADULT; ANHEDONIA; CASE REPORT; DEPRESSION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; FATIGUE; HAMILTON SCALE; HUMAN; LETTER; MALE; SLEEP DISORDER; SLEEP QUALITY; SUICIDE ATTEMPT; TREATMENT OUTCOME;

ACETAMIDES; ADULT; ANTIDEPRESSIVE AGENTS; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; HUMANS; MALE; TREATMENT OUTCOME;

EID: 84891278193     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2013.09.001     Document Type: Letter

References (6)

1. Huynh N.N., McIntyre R.S. What are the implications of the STAR*D trial for primary careα A review and synthesis. Prim Care Companion J Clin Psychiatry 2008, 10(2):91-96.
2. Connolly K.R., Thase M.E. If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies. Drugs 2011, 71(1):43-64.
3. Papakostas G.I. Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. J Clin Psychiatry 2009, 70(Suppl. 6):16-25.
4. Fornaro M., Prestia D., Colicchio S., et al. A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation. Curr Neuropharmacol 2010, 8(3):287-304.
5. Kasper S., Corruble E., Hale A., et al. Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control. Int Clin Psychopharmacol 2013, 28(1):12-19.
6. Tran P.V., Bymaster F.P., McNamara R.K., et al. Dual monoamine modulation for improved treatment of major depressive disorder. J Clin Psychopharmacol 2003, 23(1):78-86.